Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK [IMGN632]) for the Treatment of Newly Diagnosed Adverse Risk Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Novartis
Incyte Corporation
iOnctura
Massachusetts General Hospital
Novartis
Dana-Farber Cancer Institute
Auron Therapeutics, Inc.
Senti Biosciences
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
City of Hope Medical Center
Thomas Jefferson University
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
Baylor College of Medicine
M.D. Anderson Cancer Center
Massachusetts General Hospital
University of Alabama at Birmingham
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
City of Hope Medical Center
National Cancer Institute (NCI)
Johns Hopkins All Children's Hospital
AbbVie
AbbVie
Baylor College of Medicine
Baylor College of Medicine
Foghorn Therapeutics Inc.
City of Hope Medical Center
Eli Lilly and Company
Orca Biosystems, Inc.
Shenzhen TargetRx Co., Ltd.
AbbVie
Northwestern University
Nkarta, Inc.
Precigen, Inc
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals